StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.18−0.01 (-3.02%)

Close on Nov 18, 2026Market cap $2.50MP/E –Yield –

VolitionRx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

VolitionRx's operating income for the twelve months ending Jun 30, 2026 was -$19.42M. For fiscal 2025 it was -$21.74M. The highest annual figure on record is -$2.61M in fiscal 2011.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$21.74M–
FY2024Dec 31, 2024-$27.02M–
FY2023Dec 31, 2023-$35.99M–
FY2022Dec 31, 2022-$31.78M–
FY2021Dec 31, 2021-$28.33M–
FY2020Dec 31, 2020-$21.25M–
FY2019Dec 31, 2019-$16.04M–
FY2018Dec 31, 2018-$17.90M–
FY2017Dec 31, 2017-$14.70M–
FY2016Dec 31, 2016-$12.43M–
FY2015Dec 31, 2015-$10.01M–
FY2014Dec 31, 2014-$5.95M–
FY2013Dec 31, 2013-$4.58M–
FY2012Dec 31, 2012-$4.08M–
FY2011Dec 31, 2011-$2.61M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.16M–
Q1 FY2026Mar 31, 2026-$5.35M–
Q4 FY2025Dec 31, 2025-$4.82M–
Q3 FY2025Sep 30, 2025-$5.10M–
Q2 FY2025Jun 30, 2025-$6.30M–
Q1 FY2025Mar 31, 2025-$5.52M–
Q4 FY2024Dec 31, 2024-$5.78M–
Q3 FY2024Sep 30, 2024-$5.87M–
Q2 FY2024Jun 30, 2024-$6.99M–
Q1 FY2024Mar 31, 2024-$8.38M–
Q4 FY2023Dec 31, 2023-$8.74M–
Q3 FY2023Sep 30, 2023-$8.65M–
Q2 FY2023Jun 30, 2023-$9.55M–
Q1 FY2023Mar 31, 2023-$9.05M–
Q4 FY2022Dec 31, 2022-$8.01M–
Q3 FY2022Sep 30, 2022-$7.99M–
Q2 FY2022Jun 30, 2022-$8.10M–
Q1 FY2022Mar 31, 2022-$7.68M–
Q4 FY2021Dec 31, 2021-$8.79M–
Q3 FY2021Sep 30, 2021-$7.56M–
Q2 FY2021Jun 30, 2021-$5.90M–
Q1 FY2021Mar 31, 2021-$6.09M–
Q4 FY2020Dec 31, 2020-$5.66M–
Q3 FY2020Sep 30, 2020-$4.50M–
Q2 FY2020Jun 30, 2020-$5.21M–
Q1 FY2020Mar 31, 2020-$5.87M–
Q4 FY2019Dec 31, 2019-$3.72M–
Q3 FY2019Sep 30, 2019-$4.18M–
Q2 FY2019Jun 30, 2019-$4.15M–
Q1 FY2019Mar 31, 2019-$3.99M–
Q4 FY2018Dec 31, 2018-$4.26M–
Q3 FY2018Sep 30, 2018-$4.45M–
Q2 FY2018Jun 30, 2018-$4.57M–
Q1 FY2018Mar 31, 2018-$4.63M–
Q4 FY2017Dec 31, 2017-$4.04M–
Q3 FY2017Sep 30, 2017-$3.88M–
Q2 FY2017Jun 30, 2017-$3.44M–
Q1 FY2017Mar 31, 2017-$3.34M–
Q4 FY2016Dec 31, 2016-$3.48M–
Q3 FY2016Sep 30, 2016-$3.48M–

More VolitionRx figures

See a number that looks wrong?